MedTrace Logo

Fecal Microbiota Transplantation in Kidney Stone Patients

NCT05516472 · Status: RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2025-03-10

No results posted yet for this study

Summary

The purpose of this study is to measure the impact of Microbial Transplant Therapy (MTT) on 24-hour urine parameters in recurrent hypercalciuric and hyperoxaluric kidney stone formers.

Conditions

  • Kidney Stones

Interventions

DRUG

Microbial Transplant Therapy

Participants will take microbial capsules, 2 capsules daily for 7 days

DRUG

Placebo

Participants will take placebo capsules

Sponsors & Collaborators

Principal Investigators

  • Joshua Stern, MD · Intermountain Health Care, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-10
Primary Completion
2026-12-31
Completion
2027-03-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05516472 on ClinicalTrials.gov